Company Filing History:
Years Active: 1999
Title: Innovations in Gene Therapy by Alexander L Rakhmilevich
Introduction
Alexander L Rakhmilevich is a notable inventor based in Delafield, WI (US). He has made significant contributions to the field of genetic therapy, particularly in the treatment of tumors. His innovative approach has the potential to change the landscape of cancer treatment.
Latest Patents
Rakhmilevich holds 1 patent for his work on IL-12 gene therapy of tumors. This patent describes a method of delivering a genetic construction encoding the p35 and p40 subunits of the cytokine IL-12 into the cells of individuals requiring therapy. The goal is to express IL-12 in these cells, which can lead to the regression of established tumors.
Career Highlights
Rakhmilevich is associated with Powderject Vaccines, Inc., where he continues to develop innovative solutions in the field of gene therapy. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
One of his notable collaborators is Ning-Sun Yang, with whom he has worked on various projects related to gene therapy and cancer treatment.
Conclusion
Alexander L Rakhmilevich's contributions to gene therapy represent a significant advancement in the fight against cancer. His innovative approaches and dedication to research continue to inspire progress in medical science.